Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids

Gecilmara Salviato Pileggi, Cleonice Barbosa Sandoval de Souza, Virgínia Paes Leme Ferriani

Arthritis Care & Research · 2010 · 101 citations · 23 references

Abstract

VV appears to be safe in patients with juvenile rheumatic diseases receiving methotrexate, as long as continuous prospective vigilance for side effects is performed.

References

23